minichart

us corporate news

Tango Therapeutics 2025 10-K Annual Report: Business Overview, Risk Factors, and Financial Highlights

Minichart

March 6, 2026

Tango Therapeutics 2025 Annual Report: Key Investor Insights...

Continue Reading 0

us corporate news

Myers Industries, Inc. 2025 Annual Report: Business Overview, Financials, Risk Factors, and SEC Filings

Minichart

March 6, 2026

Myers Industries 2025 Annual Report - Key Investor Insights ...

Continue Reading 0

us corporate news

CLIMB BIO, INC. 2025 Annual Report: Business Overview, Risk Factors, Strategy, and Financials (Form 10-K)

Minichart

March 6, 2026

Climb Bio, Inc. 2025 Annual Report: Key Highlights & Shareho...

Continue Reading 0

us corporate news

Invivyd, Inc. 2023 Annual Report: Business Overview, Risk Factors, and Financial Statements (Form 10-K)

Minichart

March 6, 2026

Invivyd, Inc. Annual Report: Key Investor Insights Inv...

Continue Reading 0

us corporate news

Compass Therapeutics 2025 10-K: Clinical-Stage Oncology Pipeline, Risks, and Regulatory Overview

Minichart

March 6, 2026

Compass Therapeutics, Inc. 2025 Annual Report - Investor Hig...

Continue Reading 0

us corporate news

Kura Oncology, Inc. 2024 10-K Annual Report: Precision Cancer Medicines, Pipeline, and Financial Overview

Minichart

March 6, 2026

Kura Oncology 2025 Annual Report: Key Highlights and Investo...

Continue Reading 0

us corporate news

Bioventus Inc. 2025 Annual Report – Business Overview, Risk Factors, Products, and Growth Strategy

Minichart

March 6, 2026

Bioventus Inc. 2025 Annual Report - Key Investor Insights ...

Continue Reading 0

us corporate news

Distribution Solutions Group (DSG) 2025 Annual Report: Business Overview, Growth Strategies, Market Segments, and Financial Highlights

Minichart

March 6, 2026

Distribution Solutions Group, Inc. 2025 Annual Report - Key ...

Continue Reading 0

us corporate news

Silence Therapeutics plc 2025 Annual Report: siRNA Therapeutics Pipeline, Business Overview, and Regulatory Insights

Minichart

March 6, 2026

Silence Therapeutics plc 2025 Annual Report: Key Points for ...

Continue Reading 0

us corporate news

Okta, Inc. 2026 Company Overview: Identity Security, Growth Strategy, Product Offerings, and Competitive Position Insights

Minichart

March 6, 2026

Okta, Inc. 2026 Annual Report: Key Insights for Investors ...

Continue Reading 0

Author: Minichart